Effects of Metreleptin in Type 1 Diabetes Mellitus

This study is currently recruiting participants.

Verified June 2012 by University of Texas Southwestern Medical Center

Sponsor:

Collaborators:

Juvenile Diabetes Research Foundation

Amylin Pharmaceuticals, LLC.

Information provided by (Responsible Party):

Abhimanyu Garg, University of Texas Southwestern Medical Center

ClinicalTrials.gov Identifier:

NCT01268644

First received: December 29, 2010

Last updated: June 12, 2012

Last verified: June 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2013
Estimated Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)